What is HC Wainwright's Forecast for Transcat Q4 Earnings?

Transcat, Inc. (NASDAQ:TRNS - Free Report) - Analysts at HC Wainwright reduced their Q4 2025 EPS estimates for Transcat in a research note issued to investors on Wednesday, October 30th. HC Wainwright analyst S. Buck now anticipates that the scientific and technical instruments company will post earnings of $0.48 per share for the quarter, down from their prior forecast of $0.63. HC Wainwright currently has a "Buy" rating and a $156.00 target price on the stock. The consensus estimate for Transcat's current full-year earnings is $2.06 per share.

Transcat (NASDAQ:TRNS - Get Free Report) last released its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 EPS for the quarter, missing analysts' consensus estimates of $0.47 by ($0.12). The company had revenue of $67.83 million for the quarter, compared to analysts' expectations of $70.30 million. Transcat had a return on equity of 8.48% and a net margin of 5.69%. The firm's revenue for the quarter was up 8.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.41 EPS.

A number of other research firms have also recently commented on TRNS. Craig Hallum cut their target price on shares of Transcat from $138.00 to $113.00 and set a "buy" rating for the company in a research note on Wednesday. Northland Securities dropped their price objective on shares of Transcat from $130.00 to $110.00 and set a "market perform" rating for the company in a research note on Wednesday. Oppenheimer reaffirmed an "outperform" rating and set a $130.00 price objective (down previously from $155.00) on shares of Transcat in a research note on Wednesday. Finally, StockNews.com cut shares of Transcat from a "hold" rating to a "sell" rating in a research note on Tuesday. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, Transcat has an average rating of "Hold" and a consensus price target of $127.25.

Transcat Stock Performance

Shares of TRNS stock traded down $3.43 on Thursday, reaching $95.57. 90,450 shares of the company were exchanged, compared to its average volume of 52,775. The company has a market cap of $874.47 million, a price-to-earnings ratio of 56.55 and a beta of 0.67. The business has a 50-day moving average price of $122.34 and a 200 day moving average price of $121.99. Transcat has a 1 year low of $84.45 and a 1 year high of $147.12.

Institutional Trading of Transcat

Several hedge funds have recently made changes to their positions in the company. Principal Financial Group Inc. grew its stake in shares of Transcat by 8.8% in the 3rd quarter. Principal Financial Group Inc. now owns 4,611 shares of the scientific and technical instruments company's stock valued at $557,000 after buying an additional 373 shares during the period. Conestoga Capital Advisors LLC grew its stake in shares of Transcat by 17.9% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company's stock valued at $109,561,000 after buying an additional 137,830 shares during the period. US Bancorp DE grew its stake in shares of Transcat by 15.6% in the 3rd quarter. US Bancorp DE now owns 1,547 shares of the scientific and technical instruments company's stock valued at $187,000 after buying an additional 209 shares during the period. Wealth Enhancement Advisory Services LLC grew its stake in shares of Transcat by 28.8% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 79,303 shares of the scientific and technical instruments company's stock valued at $9,577,000 after buying an additional 17,743 shares during the period. Finally, Arkadios Wealth Advisors grew its stake in shares of Transcat by 38.7% in the 3rd quarter. Arkadios Wealth Advisors now owns 6,118 shares of the scientific and technical instruments company's stock valued at $739,000 after buying an additional 1,707 shares during the period. Hedge funds and other institutional investors own 98.34% of the company's stock.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.